Back to News
Market Impact: 0.32

AST SpaceMobile's Stock Is Down After Another Successful Launch: Time to Buy The Dip?

Product LaunchesTechnology & InnovationCompany FundamentalsAnalyst EstimatesAnalyst InsightsCorporate Guidance & OutlookInfrastructure & DefenseInvestor Sentiment & Positioning

AST SpaceMobile launched BlueBird satellites 8, 9, and 10 on June 17 and said BlueBirds 11-13 are in final preparation, with production already running through BlueBird 37. Management plans 45 to 60 satellites in orbit by end-2026 and up to 248 over the next few years. Analysts expect revenue to rise from $71 million in 2025 to $1.88 billion in 2028, with EBITDA turning positive in 2027, though the stock still trades about 35% below its recent high.

Analysis

The market is still pricing ASTS like a science project rather than a scaled network rollout, but the real inflection is operational cadence, not the headline launch count. Once a constellation crosses a minimum service threshold, revenue should compound nonlinearly as coverage expands, device adoption broadens, and carrier negotiations become less optional. The second-order winner is likely the telco ecosystem, especially carriers that can buy incremental rural coverage without funding dense tower builds; the loser is any competing direct-to-device architecture that depends on heavier capex per delivered bit.

The key nuance is that ASTS’ software-defined ground segment creates a longer asset life than hardware-only satellite peers, which compresses replacement risk and improves lifetime return on deployed capital if execution holds. That said, the valuation remains highly duration-sensitive: most of the implied upside sits 24–48 months out, so the stock can still underperform sharply on any launch delay, integration issue, or customer monetization slippage even if the underlying program remains intact. In other words, this is a favorable fundamental setup with an unstable mark-to-market path.

Consensus appears to be underappreciating how much of the bull case depends on dilution and funding optics rather than pure technical success. The company can be “right” on the network and still disappoint equity holders if it needs repeated capital raises before the revenue ramp becomes visible. The contrarian read is that recent weakness may be less about deteriorating thesis quality and more about investors demanding proof of commercialization before assigning infrastructure-like multiples; if the next few launches and partner announcements go cleanly, that skepticism can unwind quickly.

More News